Bicycle Therapeutics

Bicycle Therapeutics Lead Cancer Drug Combined With Merck's Blockbuster Drug Shows 60% Overall Response Rate In Urothelial Cancer Patients
Yahoo/Benzinga
Mon, 12/16/24 - 11:43 am
Bicycle Therapeutics
urothelial cancer
zelenectide pevedotin
Bicycle Therapeutics' Lead Cancer Candidate's Has High-Opportunity
Benzinga
Mon, 09/9/24 - 10:49 am
Bicycle Therapeutics
metastatic urothelial cancer
zele
Pfizer
Padcev
Bicycle Therapeutics scores $555M investment for disease prevention
Tech.eu
Fri, 05/24/24 - 11:18 am
Bicycle Therapeutics
funding
solid tumors
Bicycle Therapeutics Provides Data Updates for Three Clinical Programs and Strategy Overview at First R&D Day
BioSpace
Fri, 12/15/23 - 09:43 am
Bicycle Therapeutics
cancer
R&D
Bicycle Therapeutics raising $230m growth capital
Business Weekly
Thu, 07/13/23 - 09:01 pm
Bicycle Therapeutics
funding
Bayer and Bicycle Therapeutics Enter Strategic Collaboration for Development of Novel Targeted Radionuclide Therapies in Oncology
BioSpace
Wed, 05/10/23 - 10:04 am
Bayer
Bicycle Therapeutics
drug development
radiopharmaceuticals
Bicycle, Novartis Ink Oncology Deal Worth up to $1.7B
BioSpace
Tue, 03/28/23 - 11:30 am
Bicycle Therapeutics
Novartis
drug discovery
oncology
radioligand
ASCO-GU – Bicycle tries to put distance between itself and Seagen
EP Vantage
Thu, 02/16/23 - 10:15 am
ASCO-GU
Bicycle Therapeutics
Seagen
Padcev
urothelial cancer
BT8009
Genentech rides up to 2nd target in Bicycle immuno-oncology collab
Fierce Biotech
Tue, 07/12/22 - 10:52 am
Genentech
Bicycle Therapeutics
Roche
immuno-oncology
AACR 2022 – A weekend of updates yields few winners
EP Vantage
Tue, 04/12/22 - 10:34 am
AACR
Bicycle Therapeutics
Rubius Therapeutics
C4 Therapeutics
Zentalis
Affimed
Seagen
Astellas
Bicycle Therapeutics shares fall 23% after the company shares interim Phase 1 data
Marketwatch
Mon, 04/11/22 - 10:39 am
AACR
Bicycle Therapeutics
clinical trials
urothelial cancer
BT8009
Biopharma’s stock market winners of 2021 revealed
EP Vantage
Wed, 01/12/22 - 10:50 am
biotech stocks
Eli Lilly
Pfizer
Abbott Labs
Moderna Therapeutics
Merck KGaA
Novo Nordisk
BioNTech
Biohaven
Prothena
Bicycle Therapeutics
Bellus Health
Evolus
Struggling Ionis licenses Bicycle Therapeutics' platform in a bid to develop drugs that can cross blood-brain barrier
Endpoints
Tue, 07/13/21 - 11:42 pm
Ionis Pharmaceuticals
Bicycle Therapeutics
blood-brain barrier
drug development
Bicycle Therapeutics announces first patient dosed in phase I dose escalation of BT5528 in combination with nivolumab
Pharmaceutical Business Review
Wed, 05/6/20 - 12:10 pm
Bicycle Therapeutics
clinical trials
BT5528
nivolumab
Genentech pays Bicycle $30M upfront to form discovery-stage immuno-oncology pact
Fierce Biotech
Tue, 02/25/20 - 10:18 am
Roche
Genentech
Bicycle Therapeutics
R&D
immuno-oncology
Bicycle raises $61M in downsized IPO, joining fellow biotechs on Nasdaq who have hauled in $1.6B collectively
Endpoints
Thu, 05/23/19 - 09:57 am
Bicycle Therapeutics
IPOs
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Readouts And IPOs
Yahoo/Benzinga
Sun, 05/19/19 - 03:59 pm
Incyte
Novartis
Athersys
ResTORbio
Bellerophon Therapeutics
Eli Lilly
CymaBay
Bicycle Therapeutics
Peloton Therapeutics
Ideaya
IPOs
Bicycle Therapeutics Updates Filing for $80 Million IPO
CP Wire
Tue, 05/14/19 - 09:33 am
Bicycle Therapeutics
IPOs
drug development
Bicycle Therapeutics Updates Filing for $80 Million IPO
Tue, 05/14/19 - 09:23 am
Bicycle Therapeutics
IPOs
Bicycle hires clinical leader ahead of IPO-fueled pipeline push
Fierce Biotech
Fri, 05/10/19 - 10:23 am
Bicycle Therapeutics

Pages